Henry Schein Sees Steady Dental Demand, $125M Profit Lift by 2026
Is This the Right Time to Keep HSIC Stock in Your Portfolio?
Henry Schein, Inc. (HSIC) Presents at Stifel Jaws & Paws Conference 2026 Transcript
Henry Schein Appoints William K. Daniel As Board Chairman, Effective Immediately
3 Small-Cap Stocks We’re Skeptical Of
Assessing Henry Schein (HSIC) Valuation After Recent Uneven Share Price Performance
Henry Schein Stock: Is Wall Street Bullish or Bearish?
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness
5 Must-Read Analyst Questions From Henry Schein’s Q1 Earnings Call
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
Henry Schein, Inc. (HSIC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $85
Mizuho Maintains Neutral on Henry Schein, Lowers Price Target to $82
Henry Schein Q1 Earnings Call Highlights
Henry Schein, Inc. Q1 2026 Earnings Call Summary
Henry Schein, Inc. (HSIC) Q1 2026 Earnings Call Transcript
Henry Schein (HSIC) Q1 2026 Earnings Transcript
Henry Schein tops expectations, but shares dip slightly after results
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.